CSIMarket
 


Humanigen Inc  (HGEN)
Other Ticker:  
 

Humanigen Inc's Quick Ratio

HGEN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




HGEN Quick Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Change 11.17 % 53.02 % 33.66 % 236.64 % 362.1 %
Y / Y Cash & cash equivalent Change -67.68 % -60.97 % -25.78 % 3.36 % -16.33 %
Quick Ratio MRQ 0.32 0.61 0.97 1.02 1.11
Overall Ranking # # # # #
Seq. Current Liabilities Change -0.78 % 8.16 % 3.57 % 0.02 % 36.56 %
Seq. Cash & cash equivalent Change -47.45 % -31.77 % -1.53 % -8.48 % -36.53 %



Quick Ratio third quarter 2022 Comment
Regardless of the sequential decrease in Current Liabilities, Quick Ratio detoriated to 0.32 above company average Quick Ratio.

Within Major Pharmaceutical Preparations industry Humanigen Inc booked the highest Quick Ratio than Humanigen Inc in the third quarter 2022. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are HGEN Segments?
See Quick Ratio HGEN on the trailing twelve month basis
Quick Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Quick Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Humanigen Inc's Current Liabilities $ 76 Millions Visit HGEN's Balance sheet
Humanigen Inc's Cash & cash equivalent $ 25 Millions Visit HGEN's Balance sheet
Source of HGEN's Sales Visit HGEN's Sales by Geography


Cumulative Humanigen Inc's Quick Ratio

HGEN's Quick Ratio for the trailling 12 Months

HGEN Quick Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities TTM Growth 11.17 % 53.02 % 33.66 % 236.64 % 362.1 %
Y / Y Cash & cash equivalent TTM Growth -67.68 % -60.97 % -25.78 % 3.36 % -16.33 %
Quick Ratio TTM 0.72 0.92 1.3 1.49 1.86
Total Ranking TTM # 1750 # 2163 # 2014 # 743 # 1314
Seq. Current Liabilities TTM Growth -0.78 % 8.16 % 3.57 % 0.02 % 36.56 %
Seq. Cash & cash equivalent TTM Growth -47.45 % -31.77 % -1.53 % -8.48 % -36.53 %


TTM Quick Ratio Comment
On the trailing twelve months basis Due to decrease in Current Liabilities in the III. Quarter to $76.39 millions, average cumulative Quick Ratio decreased to 0.72 below the Humanigen Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 407 other companies have achieved higher Quick Ratio than Humanigen Inc. While overall ranking remained unchanged compare to previous quarter at no. 1750.

Explain Quick Ratio?
What are HGEN Segments?
See Quick Ratio HGEN on the trailing twelve month basis

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 408
Healthcare Sector # 759
Within the Market # 1750


TTM Quick Ratio Statistics
High Average Low
5.78 2.11 0.03
(Sep. 30, 2014)   (Mar 31 2020)




Companies with similar Quick Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2022 MRQ Cash & cash equivalentSep 30 2022 MRQ Current Liabilities
Societal Cdmo Inc   0.88 $ 11.577  Millions$ 13.105  Millions
Zoetis Inc   0.87 $ 2,507.000  Millions$ 2,880.000  Millions
Comera Life Sciences Holdings Inc   0.84 $ 2.713  Millions$ 3.235  Millions
Phibro Animal Health Corporation  0.83 $ 86.280  Millions$ 103.799  Millions
Cumberland Pharmaceuticals Inc   0.78 $ 19.542  Millions$ 25.077  Millions
Thorne Healthtech Inc   0.78 $ 22.508  Millions$ 28.971  Millions
Akebia Therapeutics Inc   0.77 $ 144.761  Millions$ 187.965  Millions
Contrafect Corporation  0.76 $ 17.648  Millions$ 23.116  Millions
180 Life Sciences Corp  0.76 $ 3.589  Millions$ 4.725  Millions
Abbott Laboratories  0.74 $ 9,907.000  Millions$ 13,365.000  Millions
Acer Therapeutics Inc   0.73 $ 6.378  Millions$ 8.685  Millions
Lannett Company Inc  0.71 $ 77.916  Millions$ 110.143  Millions
Assertio Holdings inc   0.70 $ 64.826  Millions$ 92.296  Millions
Supernus Pharmaceuticals inc   0.69 $ 391.789  Millions$ 567.517  Millions
Ani Pharmaceuticals inc  0.69 $ 56.281  Millions$ 81.627  Millions
Ptc Therapeutics inc   0.69 $ 288.432  Millions$ 420.076  Millions
Nabriva Therapeutics Plc  0.68 $ 14.647  Millions$ 21.640  Millions
Opko Health Inc   0.68 $ 180.838  Millions$ 267.272  Millions
Lftd Partners Inc   0.67 $ 4.377  Millions$ 6.574  Millions
Celularity Inc   0.62 $ 42.649  Millions$ 69.219  Millions
Exicure Inc   0.61 $ 15.646  Millions$ 25.710  Millions
Innovation Pharmaceuticals Inc   0.59 $ 3.046  Millions$ 5.131  Millions
Chimerix inc   0.59 $ 10.369  Millions$ 17.710  Millions
Xencor Inc  0.58 $ 52.654  Millions$ 90.032  Millions
Journey Medical Corporation  0.57 $ 34.891  Millions$ 60.777  Millions
One World Products Inc   0.55 $ 1.519  Millions$ 2.737  Millions
Chembio Diagnostics Inc   0.55 $ 21.055  Millions$ 38.624  Millions
Agile Therapeutics Inc  0.53 $ 6.145  Millions$ 11.653  Millions
Abvc Biopharma Inc   0.53 $ 2.048  Millions$ 3.894  Millions
Intercept Pharmaceuticals inc   0.52 $ 114.320  Millions$ 221.584  Millions

Date modified: 2022-11-16T06:37:39+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SR's Profile

Stock Price

SR's Financials

Business Description

Fundamentals

Charts & Quotes

SR's News

Suppliers

SR's Competitors

Customers & Markets

Economic Indicators

SR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071